DK168272B1 - Præparat til terapeutisk og diagnostisk anvendelse samt fremgangsmåde til bestemmelse af tilstedeværelse af toxin fra Shigella Dysenteriae - Google Patents

Præparat til terapeutisk og diagnostisk anvendelse samt fremgangsmåde til bestemmelse af tilstedeværelse af toxin fra Shigella Dysenteriae Download PDF

Info

Publication number
DK168272B1
DK168272B1 DK347784A DK347784A DK168272B1 DK 168272 B1 DK168272 B1 DK 168272B1 DK 347784 A DK347784 A DK 347784A DK 347784 A DK347784 A DK 347784A DK 168272 B1 DK168272 B1 DK 168272B1
Authority
DK
Denmark
Prior art keywords
toxin
galp
shigella dysenteriae
sub
therapeutic
Prior art date
Application number
DK347784A
Other languages
Danish (da)
English (en)
Other versions
DK347784D0 (da
DK347784A (da
Inventor
Karl-Anders Karlsson
Alf Anton Lindberg
Original Assignee
Symbicom Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Symbicom Ab filed Critical Symbicom Ab
Publication of DK347784D0 publication Critical patent/DK347784D0/da
Publication of DK347784A publication Critical patent/DK347784A/da
Application granted granted Critical
Publication of DK168272B1 publication Critical patent/DK168272B1/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/04—Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
    • G01N2333/24—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • G01N2333/25—Shigella (G)
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/803—Physical recovery methods, e.g. chromatography, grinding

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Analytical Chemistry (AREA)
  • Biophysics (AREA)
  • Epidemiology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
  • Percussion Or Vibration Massage (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DK347784A 1983-07-15 1984-07-13 Præparat til terapeutisk og diagnostisk anvendelse samt fremgangsmåde til bestemmelse af tilstedeværelse af toxin fra Shigella Dysenteriae DK168272B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE8304007A SE8304007D0 (sv) 1983-07-15 1983-07-15 Forening och komposition for terapeutisk eller diagnostisk anvendning samt forfarande for terapeutisk behandling
SE8304007 1983-07-15

Publications (3)

Publication Number Publication Date
DK347784D0 DK347784D0 (da) 1984-07-13
DK347784A DK347784A (da) 1985-01-16
DK168272B1 true DK168272B1 (da) 1994-03-07

Family

ID=20351988

Family Applications (1)

Application Number Title Priority Date Filing Date
DK347784A DK168272B1 (da) 1983-07-15 1984-07-13 Præparat til terapeutisk og diagnostisk anvendelse samt fremgangsmåde til bestemmelse af tilstedeværelse af toxin fra Shigella Dysenteriae

Country Status (9)

Country Link
US (1) US4724205A (xx)
EP (1) EP0132242B1 (xx)
JP (1) JPS6064927A (xx)
AT (1) ATE96324T1 (xx)
AU (1) AU581851B2 (xx)
DE (1) DE3486236T2 (xx)
DK (1) DK168272B1 (xx)
FI (1) FI842815A (xx)
SE (1) SE8304007D0 (xx)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU561067B2 (en) * 1982-03-22 1987-04-30 Biocarb Ab Anti-bacterial composition containing an oligosaccharide
SE8304006D0 (sv) * 1983-07-15 1983-07-15 Karlsson Karl Anders Forening och komposition for terapeutisk eller diagnostisk anvendning samt forfarande for terapeutisk behandling
SE8406626D0 (sv) * 1984-12-27 1984-12-27 Bio Carb Ab Forening och komposition for terapeutisk eller diagnostisk anvendning jemte anvendning av sadan forening och komposition for terapeutisk behandling och isolering av shigatoxin
DK17885D0 (da) * 1985-01-14 1985-01-14 Karlsson Karl Anders Antiviralt middel
US5217715A (en) * 1988-08-01 1993-06-08 The United States Of America As Represented By The Department Of Health And Human Services Carbohydrate receptor for bacteria and method for use thereof
DK455088D0 (da) * 1988-08-12 1988-08-12 Symbicom Ab Syntetiske receptoranaloger
SE9003222L (sv) * 1990-10-10 1992-04-11 Jens Sandros Preparat foer profylaktiskt,terapeutiskt och diagnostiskt bruk vid infektioner
US5310542A (en) * 1991-12-31 1994-05-10 Lever Brothers Company, Division Of Conopco, Inc. Oral hygiene compositions containing antiplaque agents
US5409902A (en) * 1991-12-31 1995-04-25 Lever Brothers Company Oral hygiene compositions containing glyceroglycolipids as antiplaque compounds
US6727061B2 (en) * 1997-02-20 2004-04-27 Cabtec, Inc. Methods for identifying species or Shigella and E. coli using operon sequence analysis
US5888750A (en) * 1997-05-30 1999-03-30 Synsorb Biotech, Inc. Method of recovering shiga-like toxins and vaccines comprising inactivated shiga-like toxin
US7135173B2 (en) * 2000-07-13 2006-11-14 Idaho Research Foundation, Inc. Antiviral activity of Shiga toxin
US6541013B1 (en) 2000-07-13 2003-04-01 Idaho Research Foundation, Inc. Methods and compositions for suppressing bovine leukemia virus with a Shiga toxin polypeptide

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1188519A (en) * 1966-10-27 1970-04-15 Wellcome Found Method for the Purification of Lipopolysaccharides
US3891508A (en) * 1973-06-01 1975-06-24 Joseph M Merrick Method of rapid identification of gram-negative bacteria
SE8001748L (sv) * 1980-03-05 1981-09-06 Kaellenius Gunilla Kompositioner for terapeutisk eller diagnostisk anvendning jemte forfarande for terapeutik
EP0058665B1 (en) * 1980-05-09 1986-02-26 LEFFLER, Hakon Carbohydrate derivatives for inhibiting bacterial adherence
EP0089940A1 (en) * 1982-03-23 1983-09-28 BioCarp AB Compositions for therapeutic or diagnostic use containing oligosaccharides
SE8304006D0 (sv) * 1983-07-15 1983-07-15 Karlsson Karl Anders Forening och komposition for terapeutisk eller diagnostisk anvendning samt forfarande for terapeutisk behandling

Also Published As

Publication number Publication date
DE3486236D1 (de) 1993-12-02
FI842815A (fi) 1985-01-16
EP0132242B1 (en) 1993-10-27
AU581851B2 (en) 1989-03-09
DK347784D0 (da) 1984-07-13
EP0132242A2 (en) 1985-01-23
EP0132242A3 (en) 1989-02-08
ATE96324T1 (de) 1993-11-15
AU3052884A (en) 1985-01-17
SE8304007D0 (sv) 1983-07-15
US4724205A (en) 1988-02-09
DK347784A (da) 1985-01-16
JPS6064927A (ja) 1985-04-13
FI842815A0 (fi) 1984-07-12
DE3486236T2 (de) 1994-02-24

Similar Documents

Publication Publication Date Title
DK168272B1 (da) Præparat til terapeutisk og diagnostisk anvendelse samt fremgangsmåde til bestemmelse af tilstedeværelse af toxin fra Shigella Dysenteriae
Gupta et al. Pili and lipopolysaccharide of Pseudomonas aeruginosa bind to the glycolipid asialo GM1
Smyth et al. Differences in hydrophobic surface characteristics of porcine enteropathogenic Escherichia coli with or without K88 antigen as revealed by hydrophobic interaction chromatography
Bock et al. Specificity of binding of a strain of uropathogenic Escherichia coli to Gal alpha 1—-4Gal-containing glycosphingolipids.
Shenep et al. Kinetics of endotoxin release during antibiotic therapy for experimental gram-negative bacterial sepsis
Sönju et al. Electron microscopy, carbohydrate analyses and biological activities of the proteins adsorbed in two hours to tooth surfaces in vivo
DE69433901T2 (de) Verbindungen und pharmazeutische zusammensetzungen zur behandlung und prophylaxe bakterieller infektionen
Stromberg et al. Identification of carbohydrate structures that are possible receptors for Neisseria gonorrhoeae.
EP0058665A1 (en) CARBOHYDRATE DERIVATIVES FOR INHIBITING BACTERIAL ADHESION.
EP0089938A1 (en) Compositions for therapeutic or diagnostic use containing oligosaccharides
DE69834808T2 (de) Multiple,kohlenhydrathaltige glycopeptid-antigene, daraus entwickelte impfstoffe sowie deren verwendung
EP0133170A2 (en) A compound and a composition for therapeutic or diagnostic use and a method for therapeutic treatment
Rombouts et al. Structural analysis of an unusual bioactive N-acylated lipo-oligosaccharide LOS-IV in Mycobacterium marinum
EP0689842A1 (en) Use of an organic extract of cinnamon plant to inhibit growth of helicobacter pylori
JPH0643318B2 (ja) マイコプラズマ ニューモニエ及びマイコプラズマホミヌスのスルファチドへの接着
US5322699A (en) Leukocyte-derived CR3 modulator, integrin modulating factor-1 (IMF-1)
Mantle et al. Adhesion of Yersinia enterocolitica to purified rabbit and human intestinal mucin
EP0089939A1 (en) Compositions for therapeutic or diagnostic use containing oligosaccharides
US5696000A (en) Adhesion receptors for pathogenic or opportunistic microorganisms
Mayberry Cellular distribution and linkage of D-(-)-3-hydroxy fatty acids in Bacteroides species
Leite et al. Prior exposure to Mannheimia haemolytica leukotoxin or LPS enhances β2-integrin expression by bovine neutrophils and augments LKT cytotoxicity
Holmgren Receptors for cholera toxin and Escherichia coli heat-labile enterotoxin revisited
Fathy et al. Chemical constituents of date palm (Phoenix dactylifera L.) fruit-free bunches and their biological activities
Luk et al. Epitope mapping of four monoclonal antibodies recognizing the hexose core domain of Salmonella lipopolysaccharide.
EP0205547A1 (en) A compound and a composition for therapeutic or diagnostic use and the use of such compound and composition for therapeutic treatment and isolation of shigatoxine

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PBP Patent lapsed